Language selection

Search

2011-12-15 - Male - 36 Years old

394603

Adverse reaction report number 394603
Latest AER version number 0
Market authorization holder AER number ALL1201301039
Initial received date 2011-12-15
Latest received date 2011-12-15
Age 36 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report Community
Report outcome Recovered/resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 10MGCAPSULE, EXTENDED RELEASESuspectOral10 Milligram1 every 1 Day(s)24 Day(s)Disturbance in attention
REMERON RDTABLET (ORALLY DISINTEGRATING)Concomitant
TEMAZEPAMCAPSULEConcomitant

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Pain in extremity
Rash
Date modified: